1. Home
  2. ASMB vs FNWB Comparison

ASMB vs FNWB Comparison

Compare ASMB & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • FNWB
  • Stock Information
  • Founded
  • ASMB 2005
  • FNWB 1923
  • Country
  • ASMB United States
  • FNWB United States
  • Employees
  • ASMB N/A
  • FNWB 270
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • FNWB Banks
  • Sector
  • ASMB Health Care
  • FNWB Finance
  • Exchange
  • ASMB Nasdaq
  • FNWB Nasdaq
  • Market Cap
  • ASMB 84.5M
  • FNWB 95.2M
  • IPO Year
  • ASMB 2010
  • FNWB 2015
  • Fundamental
  • Price
  • ASMB $13.30
  • FNWB $10.86
  • Analyst Decision
  • ASMB Buy
  • FNWB Hold
  • Analyst Count
  • ASMB 2
  • FNWB 1
  • Target Price
  • ASMB $35.00
  • FNWB $12.00
  • AVG Volume (30 Days)
  • ASMB 22.6K
  • FNWB 15.9K
  • Earning Date
  • ASMB 03-27-2025
  • FNWB 01-29-2025
  • Dividend Yield
  • ASMB N/A
  • FNWB 2.59%
  • EPS Growth
  • ASMB N/A
  • FNWB N/A
  • EPS
  • ASMB N/A
  • FNWB N/A
  • Revenue
  • ASMB $28,326,000.00
  • FNWB $50,900,000.00
  • Revenue This Year
  • ASMB $282.16
  • FNWB N/A
  • Revenue Next Year
  • ASMB N/A
  • FNWB $11.60
  • P/E Ratio
  • ASMB N/A
  • FNWB N/A
  • Revenue Growth
  • ASMB N/A
  • FNWB N/A
  • 52 Week Low
  • ASMB $11.01
  • FNWB $8.91
  • 52 Week High
  • ASMB $19.93
  • FNWB $16.00
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 38.89
  • FNWB 60.31
  • Support Level
  • ASMB $13.13
  • FNWB $10.80
  • Resistance Level
  • ASMB $14.25
  • FNWB $11.10
  • Average True Range (ATR)
  • ASMB 0.55
  • FNWB 0.22
  • MACD
  • ASMB -0.07
  • FNWB 0.03
  • Stochastic Oscillator
  • ASMB 15.38
  • FNWB 75.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: